Likely active: new fund Jun 2023 Verified 5 Nov 2026
PruVen Capital
Palo Alto, CA multi-stage venture firm whose LPs are financial services and insurance groups. It invests seed to growth in enterprise IT and B2B AI plus insurtech, fintech, healthcare and proptech, in the US, Europe, LatAm and SE Asia.
- Type
- VC firm
- Location
- Palo Alto, California, United States
- Stages
- Seed, Series A, Series B, Growth
- Backs
- B2B software, Fintech, Medtech and digital health
- Sectors
- AI, Fintech, Healthtech and life sciences, Insurtech, B2B, Proptech
- Fund size / AUM
- $371M PruVen Capital Partners Fund II (Form D offering, 2023); $703.4M gross private fund assets (Form ADV; private funds: 2, of which venture capital: 2)
- Latest fund or filing
- 7 Aug 2024
- Portfolio mix
- B2B software 53%; Fintech 33%; Medtech and digital health 10%; Biotech and pharma 3% (n=30)
- Website
- www.pruvencap.com
Contacts on file
For PruVen Capital, the paid file holds: 4 named decision-makers with roles.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
NewfrontDataRobotBilt RewardsPismoTrustLayer
Sources
- www.sec.gov/Archives/edgar/data/1976361/000196852024000002/
- adviserinfo.sec.gov/firm/summary/310165
- www.pruvencap.com/
- www.pruvencap.com/portfolio/
- www.pruvencap.com/team/
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 120 lists
Growth-stage insurtech investors in the US (15)Series B proptech investors (18)Series B insurtech investors (21)Series A proptech investors in the US (21)Proptech investors in the San Francisco Bay Area (22)Series A insurtech investors in the US (23)Series B B2B investors in the US (27)Series B investors in Silicon Valley (29)Growth-stage insurtech investors (29)Growth-stage proptech investors (32)Proptech investors in California (35)Series B medtech investors in the US (36)Series A insurtech investors (40)Medtech investors in Silicon Valley (40)Growth-stage investors in Silicon Valley (41)Seed insurtech investors in the US (41)Series B B2B investors (46)B2B investors in Silicon Valley (47)Series A proptech investors (48)Growth-stage B2B investors in the US (54)Insurtech venture capital firms in the US (56)Series B medtech investors (57)Series B fintech investors in the US (59)Series B investors in California (60)Seed insurtech investors (61)Fintech investors in Silicon Valley (62)Seed proptech investors in the US (63)Series A investors in Silicon Valley (67)Series B healthtech investors in the US (69)Growth-stage medtech investors in the US (69)Growth-stage investors in the San Francisco Bay Area (71)Medtech investors in the San Francisco Bay Area (76)Series A medtech investors in the US (76)Series A B2B investors in the US (79)B2B investors in the San Francisco Bay Area (84)Insurtech investors (88)Growth-stage investors in California (89)Healthtech investors in Silicon Valley (91)Medtech investors in California (92)Proptech venture capital firms in the US (96)Growth-stage fintech investors in the US (97)Seed proptech investors (103)Growth-stage medtech investors (107)Series B SaaS investors in the US (108)B2B investors in California (109)Series A investors in the San Francisco Bay Area (112)Growth-stage B2B investors (119)Growth-stage healthtech investors in the US (121)Series A medtech investors (125)Series B AI investors in the US (126)Series B fintech investors (127)Series A investors in California (136)Fintech investors in the San Francisco Bay Area (140)Series A fintech investors in the US (145)Seed investors in Silicon Valley (152)Series A B2B investors (157)Proptech investors (159)Series B healthtech investors (160)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Series A healthtech investors in the US (164)Series B investors in the US (165)SaaS investors in Silicon Valley (169)AI investors in Silicon Valley (172)Healthtech investors in the San Francisco Bay Area (182)Seed B2B investors in the US (183)Fintech investors in California (189)Series B SaaS investors (196)Series B AI investors (204)Seed medtech investors in the US (205)Growth-stage fintech investors (214)Healthtech investors in California (240)Series A SaaS investors in the US (256)B2B venture capital firms in the US (257)Seed medtech investors (278)Series A AI investors in the US (280)Growth-stage investors in the US (288)Series A fintech investors (294)Growth-stage AI investors (295)Seed B2B investors (302)Growth-stage healthtech investors (316)Seed investors in the San Francisco Bay Area (324)Series B investors (339)Venture capital firms in Silicon Valley (341)Growth-stage SaaS investors (344)SaaS investors in the San Francisco Bay Area (347)Seed fintech investors in the US (349)Medtech venture capital firms in the US (350)AI investors in the San Francisco Bay Area (364)Series A investors in the US (372)Series A healthtech investors (401)Seed investors in California (415)SaaS investors in California (433)Seed healthtech investors in the US (437)B2B investors (438)Medtech investors (457)AI investors in California (464)Series A SaaS investors (475)Series A AI investors (500)Fintech venture capital firms in the US (525)Seed fintech investors (584)Seed SaaS investors in the US (666)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Seed AI investors in the US (724)Venture capital firms in the San Francisco Bay Area (768)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Seed SaaS investors (1,010)Venture capital firms in California (1,038)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Seed AI investors (1,082)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)AI investors (1,576)Seed investors (1,892)Venture capital firms in the US (2,975)